RITUXIMAB TREATMENT EFFICACY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS REFRACTORY TO STANDARD THERAPY IN THE LONG-TERM FOLLOW-UP

Objective. To evaluate the efficacy and safety of rituximab (RTM) treatment in the long-term follow-up of patients with systemic lupus erythematosus (SLE) refractory to standard therapy. Material and methods. RTM therapy was prescribed to 97 SLE patients with high disease activity and insufficient e...

Полное описание

Библиографические подробности

Главные авторы:	M. E. Tsanyan, S. K. Soloviev, A. V. Torgashina, E. N. Aleksandrova, S. G. Radenska-Lopovok, E. V. Nikolaeva, E. L. Nasonov
Формат:	Artigo
Язык:	Russo
Опубликовано:	IMA PRESS LLC 2014-06-01
Серии:	Научно-практическая ревматология
Предметы:	systemic lupus erythematosus rituximab long-term follow-up b-cells depletion.
Online-ссылка:	https://rsp.mediar-press.net/rsp/article/view/1919
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!